Tadashi Nakamura
Geen lopende functies
Loopbaan van Tadashi Nakamura
Eerdere bekende functies van Tadashi Nakamura
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
UNIGEN Inc.
UNIGEN Inc. Pharmaceuticals: MajorHealth Technology UNIGEN Inc. engages in the contract manufacturing of biopharmaceuticals. It develops vaccines targeting influenza, norovirus, rotavirus and others. The company was founded on May 18, 2010 and is headquartered in Akita, Japan. | Directeur/Bestuurslid | 01-01-2012 | - |
UMN PHARMA INC. | Directeur/Bestuurslid | 01-09-2006 | - |
Corporate Officer/Principal | 01-09-2006 | - |
Opleiding van Tadashi Nakamura
Gunma University | Doctorate Degree |
Statistieken
Internationaal
Japan | 4 |
Operationeel
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
UMN Pharma, Inc.
UMN Pharma, Inc. Pharmaceuticals: MajorHealth Technology UMN Pharma, Inc. engages in the development, manufacture, and sale of biopharmaceuticals. It operates through a following business division: Next-generation biopharmaceutical in-house development business and Biopharmaceutical contract manufacturing business. The Next-generation biopharmaceutical in-house development business engages in the research and development of next-generation logical vaccine by integrating next-generation biopharmaceutical drug substance manufacturing technology, adjuvant technology and drug delivery technology. The Biopharmaceutical contract manufacturing business offers study samples, investigational drugs, products, and various evaluation test results. The company was founded by Masahiro Michishita and Shuichi Kanazashi on April 20, 2004 and is headquartered in Akita, Japan. | Health Technology |
UNIGEN Inc.
UNIGEN Inc. Pharmaceuticals: MajorHealth Technology UNIGEN Inc. engages in the contract manufacturing of biopharmaceuticals. It develops vaccines targeting influenza, norovirus, rotavirus and others. The company was founded on May 18, 2010 and is headquartered in Akita, Japan. | Health Technology |
- Beurs
- Insiders
- Tadashi Nakamura
- Ervaring